Bharat Biotech’s Covaxin effective against Coronavirus strains found in India and UK

A study published in medical journal Clinical Infectious Diseases said that Covaxin has been found to successfully neutralise all key emerging variants tested including- the double mutant strain B.1.617 and B.1.1.7.

Indigenously developed Bharat Biotech’s COVID-19 vaccine – COVAXIN, has been found effective against Coronavirus strains found in India and the UK.

A study published in medical journal Clinical Infectious Diseases said that Covaxin has been found to successfully neutralise all key emerging variants tested including- the double mutant strain B.1.617 and B.1.1.7.

advt

The study was conducted by National Institute of Virology and Indian Council of Medical Research (ICMR). COVAXIN is one of the three COVID-19 vaccines that are currently available in India.

Days ago, Covaxin became the first COVID-19 vaccine to receive a nod by the Drugs Controller General of India (DCGI) for conducting Phase 2-3 trials on 2-18-year-olds in India.

The trials are expected to be completed in the next 2-3 months.

Tags

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button